Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 1581-1582, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guinarte, J. C.
Right arrow Articles by Tutor, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guinarte, J. C.
Right arrow Articles by Tutor, J. C.
Related Collections
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 1998;44:1581-1582.)
© 1998 American Association for Clinical Chemistry, Inc.

Letters

Modification of the Abbott Cyclosporine Monoclonal Whole Blood Assay

J. Carlos Guinarte, Luis F. Pérez, and J. Carlos Tutora

Laboratorio Central, Hospital General de Galicia, 15705 Santiago de Compostela, Spain
a Author for correspondence. Fax 34-81-570-102


To the Editor:

Abbott Laboratories recommends that before every Cyclosporine Monoclonal Whole Blood Assay run on the TDx analyzer, a probe cleaning procedure be performed (1) to avoid an artifactual decrease of results in the first carousel position (2).

We asked whether non-use of this procedure significantly affected results for the sample in the first carousel position. In our study, the TDx analyzer underwent daily, weekly, and monthly maintenance, as recommended by the . . . [Full Text of this Article]


Footnotes


References






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.